Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ring chromosome 4 syndrome is an autosomal anomaly characterized by variable clinical features, most commonly including significant intrauterine and postnatal growth retardation, developmental delay, intellectual disability, microcephaly, and dysmorphic facial features. Some less frequent features are cleft lip and/or cleft palate, congenital cardiovascular, gastrointestinal and genitourinary system anomalies.
Features include very common findings: Split hand; and common findings: Aplasia/Hypoplasia of the radius. 4 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 2 | Split hand, Abnormality of the upper limb |
Biomarker and diagnostic research for ring chromosome 4 has been reported in the published literature.
Phenotype severity distribution: 1 very common feature, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ring chromosome 4.
155 publications have been identified in PubMed for ring chromosome 4. Research spans Epidemiology / Natural History (40%), Basic Science / Preclinical (23%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 62 | 40% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 8:30 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
35 |
23% |
Research summaries | 28 | 18% |
Clinical study results | 14 | 9% |
Testing and diagnosis research | 10 | 6% |
Patient case studies | 4 | 3% |
New treatment approaches | 2 | 1% |
Lally JS (2026). [PMID: 41707238](https://pubmed.ncbi.nlm.nih.gov/41707238/). *Acad Med*. [Epidemiology / Natural History]
Lin JJ (2026). [PMID: 42245743](https://pubmed.ncbi.nlm.nih.gov/42245743/). *Front Oncol*. [Diagnostic / Biomarker]
GBD 2023 Diarrhoeal Disease and Enteric Infectious Diseases Collaborators (2026). [PMID: 42229499](https://pubmed.ncbi.nlm.nih.gov/42229499/). *Lancet Infect Dis*. [Epidemiology / Natural History]
Qin M (2026). [PMID: 41497125](https://pubmed.ncbi.nlm.nih.gov/41497125/). *Ann Med Surg (Lond)*. [Basic Science / Preclinical]
Bance-Anicama DI (2026). [PMID: 41746020](https://pubmed.ncbi.nlm.nih.gov/41746020/). *Trop Med Infect Dis*. [Epidemiology / Natural History]
Miro JM (2026). [PMID: 40907699](https://pubmed.ncbi.nlm.nih.gov/40907699/). *Clin Microbiol Infect*. [Epidemiology / Natural History]
Huang D (2026). [PMID: 42255896](https://pubmed.ncbi.nlm.nih.gov/42255896/). *Front Pediatr*. [Epidemiology / Natural History]
Patel M (2026). [PMID: 42127933](https://pubmed.ncbi.nlm.nih.gov/42127933/). *Lancet Neurol*. [Basic Science / Preclinical]
Yuxi L (2026). [PMID: 41496676](https://pubmed.ncbi.nlm.nih.gov/41496676/). *Ophthalmic Epidemiol*. [Epidemiology / Natural History]
Mwale M (2026). [PMID: 41621116](https://pubmed.ncbi.nlm.nih.gov/41621116/). *Vaccine*. [Epidemiology / Natural History]